neuMirRx wins new US patent for drug formulation technology
The rights to this patent and related proprietary technology, the neuNanoParticle, have been obtained by neuMirRx Corp through an exclusive license arrangement with Formatech of Andover, Massachusetts. According
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.